Frequently Asked Questions
The market is segmented based on Global Small Molecule Active Pharmaceutical Ingredient (API) Market Segmentation, By Type (Synthetic/Chemical API, Biological API), Therapeutic Type (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Dermatology, Urology), Manufacturing Method (In-House, Contract), Application (Clinical, Commercial) – Industry Trends and Forecast to 2031.
.
The Global Small Molecule Api Market size was valued at USD 195.31 USD Million in 2023.
The Global Small Molecule Api Market is projected to grow at a CAGR of 5.55% during the forecast period of 2024 to 2031.
The major players operating in the market include , Albemarle Corporation , Allergan , Aurobindo Pharma , Cambrex Corporation , Dr. Reddy's Laboratories Ltd , GSk plc , Lonza , Merck KGaA , Novartis AG , Pfizer , Siegfried Holding AG , Sun Pharmaceutical Industries Ltd , Teva Pharmaceutical Industries , Johnson Matthey , Gilead Sciences , BASF SE .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
